Literature DB >> 1940466

In vivo stability of heterogeneous expression classes in clinical isolates of methicillin-resistant staphylococci.

A M Figueiredo1, E Ha, B N Kreiswirth, H de Lencastre, G J Noel, L Senterfit, A Tomasz.   

Abstract

To define the stability of methicillin-resistant Staphylococcus aureus (MRSA) in vivo, 22 isolates collected at one New York institution in 1989 and 1990 were studied. All 22 belonged to one of two distinct methicillin-resistant phenotypes (class 3 or 2), which were precisely identified as belonging to two distinct genotypes. Genotypic classification was based on restriction analysis of chromosomal DNA with EcoRI and HindIII and Southern analysis of ClaI digests using two DNA probes. One was specific for the mec gene; the other was specific for transposon Tn554. The findings suggest that the MRSA isolates studied were representative of two genetically distinct MRSA "clones," each with a unique strain-specific methicillin-resistant phenotype that is stable under the conditions of invasive disease, carriage, and spread from patient to patient.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940466     DOI: 10.1093/infdis/164.5.883

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  Mutation frequencies and antibiotic resistance.

Authors:  J L Martinez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Detection of an archaic clone of Staphylococcus aureus with low-level resistance to methicillin in a pediatric hospital in Portugal and in international samples: relics of a formerly widely disseminated strain?

Authors:  R Sá-Leão; I Santos Sanches; D Dias; I Peres; R M Barros; H de Lencastre
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus.

Authors:  Miriam Ender; Nadine McCallum; Rajan Adhikari; Brigitte Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression.

Authors:  J E Finan; A E Rosato; T M Dickinson; D Ko; Gordon L Archer
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  Methicillin-resistant Staphylococcus aureus isolates recovered from a New York City hospital: analysis by molecular fingerprinting techniques.

Authors:  H de Lencastre; A de Lencastre; A Tomasz
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Effect of exogenous glycine on peptidoglycan composition and resistance in a methicillin-resistant Staphylococcus aureus strain.

Authors:  B L de Jonge; Y S Chang; N Xu; D Gage
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

7.  Evidence for the geographic spread of a methicillin-resistant Staphylococcus aureus clone between Portugal and Spain.

Authors:  I S Sanches; M Ramirez; H Troni; M Abecassis; M Padua; A Tomasz; H de Lencastre
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Genetic control of population structure in heterogeneous strains of methicillin resistant Staphylococcus aureus.

Authors:  H de Lencastre; A M Figueiredo; A Tomasz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

9.  Methicillin-resistant Staphylococcus aureus disease in a Portuguese hospital: characterization of clonal types by a combination of DNA typing methods.

Authors:  H de Lencastre; I Couto; I Santos; J Melo-Cristino; A Torres-Pereira; A Tomasz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

10.  Unusually large number of methicillin-resistant Staphylococcus aureus clones in a Portuguese hospital.

Authors:  I Couto; J Melo-Cristino; M L Fernandes; T Garcia; N Serrano; M J Salgado; A Torres-Pereira; I S Sanches; H de Lencastre
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.